Swing Therapeutics develops digital treatments and services in disease areas where patients are not well-served and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) such as fibromyalgia, where central pain sensitization is a significant factor. The company is investing in research to support the development of prescription-based digital therapies and services. Its near-term goal is to validate its digital therapy and bring it to market as an FDA-cleared prescription digital therapeutic. Swing Therapeutics was founded in 2019 and is based in San Francisco, California.

Swing Therapeutics develops digital treatments and services in disease areas where patients are not well-served and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) such as fibromyalgia, where central pain sensitization is a significant factor. The company is investing in research to support the development of prescription-based digital therapies and services. Its near-term goal is to validate its digital therapy and bring it to market as an FDA-cleared prescription digital therapeutic. Swing Therapeutics was founded in 2019 and is based in San Francisco, California.

Bardavon partners with employers to support the health of their employees’ movement with both preventative and post-injury physical therapy solutions offered at work, in clinic, and at home.